CN1357636A - CpG insular methylation test reagent kit and its application - Google Patents
CpG insular methylation test reagent kit and its application Download PDFInfo
- Publication number
- CN1357636A CN1357636A CN 01129967 CN01129967A CN1357636A CN 1357636 A CN1357636 A CN 1357636A CN 01129967 CN01129967 CN 01129967 CN 01129967 A CN01129967 A CN 01129967A CN 1357636 A CN1357636 A CN 1357636A
- Authority
- CN
- China
- Prior art keywords
- primer
- gene
- cpg
- medicine
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to gene determining technology and is especially CpG insular methlation test reagent kit and its application for diagnosing tumor and screening demethylation medicine. The reagent kit includes primer, medicine for extracting template DNA, medicine for modifying genome, medicine for purifying DNA, specific MSP-PCR reaction system and negative and positive contrast samples. The present invention utilizes human gene sequences and designs primer based on base mismatch principle, and different gene primer is selected to constitute different reagent kit for detecting different diseases. The present invention may be used widely in the diagnosis of cancer and the screening of relevant medicine.
Description
Technical field
The present invention relates to technique of gene detection, specifically be meant the CpG island methylation detection kit and the application thereof that are used for diagnosing tumor, demethylation drug screening.
Background technology
The CpG island is one section zone of DNA, and length is about 0.5～2.6kb.CpG island right and wrong are methylated in healthy tissues.But in human malignancies, it is one of the most general gene unconventionality phenomenon that can be identified that dna methylation changes.Many specific genes are handled district's hyper-methylation and are generally betided in malignant tumour in early days.
Measure at present 5 '-the methylated method in CpG island has Southern blot, principle is to utilize can not cut the sequence that contains one or several methylated CpG site to the responsive restriction enzyme that methylates, this method provides the estimation CpG island situation that totally methylates, require a large amount of DNA compositions, it can provide the information that methylates in CpG site within the restriction enzyme institute energy recognition sequence that methylates responsive; Another kind method is to utilize the responsive restriction enzyme that methylates in conjunction with the method for PCR, and the DNA lining after the enzymic digestion is covered with the primer amplification of restriction site, has only that the CpG site is methylated just to provide complete template.This method also can only provide the information that methylates of the CpG site in the restriction enzyme identification range, and non-methylated DNA must limit fully, digests incomplete DNA and can produce false positive.
People methylate for seeking detection CpG island, have carried out long-term deep research, have drawn gene inactivation and the tumour and the leukemic relation of the hyper-methylation on number of C pG island, for the Clinics and Practices cancer provides new way.But there is no at home and abroad at present that the related detection oncogene methylates and the demethylation test kit is produced, sold and used the report of aspect.
Summary of the invention
The objective of the invention is to utilize present result of study, develop a kind of CpG of detected object easily island and have or not the test kit that methylates and screen the demethylation medicine, and be applied to diagnose relevant disease and screen relevant medicine.
CpG island methylation detection kit includes following medicine:
(1) primer
Utilize the gene order of human genome, according to the base mispairing principle, it is P that primer is selected from last two genes of cell cycle
15 INK4B, P
16 INK4AGene, pancreas oncogene CPG, protein kinase related protein gene CPG, mastocarcinoma gene 2CPG, acute leukemia genes involved, the generegulation factor 3 genes, the generegulation factor 27 genes, GTP kinase-associated protein 27 genes, GTP kinase-associated protein gene 27B, any in the GTP kinase-associated protein gene 2L primer;
(2) medicine of extraction template DNA
1. include the DNA extraction liquid of the Proteinase K of 200～400 μ g/ml,
2. saturated phenol/chloroform/primary isoamyl alcohol system, their volume ratio are 20～25: 20～25: 1,
3. sodium-acetate,
4. lymphocyte layering liquid;
(3) genomic modification medicine:
1. silicon essence,
2. quinhydrones,
3. sodium bisulfite,
4. mineral oil;
(4) the DNA purifying medicine behind the genomic modification
1. DNA purifying DEAE resin,
2. Virahol;
(5) specificity MSP-PCR reaction system
1. the PCR damping fluid that methylates, 10 * buffer,
2. four kinds of Nucleotide are dNTP,
③MgCl
2，
4. high temperature resistant polysaccharase is the Taq enzyme;
(6) positive and negative control sample
1. the positive sample Raji cell that methylates,
2. the non-HL that methylates of negative sample
60Cell.
Saturated phenol is meant the saturated phenol of Tutofusin tris with 50mmol/L in the medicine of extraction template DNA; Saturated phenol/chloroform/primary isoamyl alcohol volume ratio is 24: 24: 1.
Genetic modification is meant the silicon essence of crossing with conventional DNA purification process purifying with silicon essence in the medicine, and quinhydrones and sodium bisulfite adopt analytical pure dry powder.
The application of CpG island methylation detection kit comprises the collection of conventional sample; Extracting genome DNA, modification and purifying is characterized in that:
(1) in the genomic modification:
1. the smart DNA consumption of purifying silicon is 0.51～2 μ g/ part,
2. the fresh preparation of quinhydrones: with the quinhydrones constant volume of 10～13mg in 10ml ultra-clean water,
3. the fresh preparation of sodium bisulfite: with the sodium bisulfite constant volume of 2.9～3.2g in 10ml ultra-clean water,
4. the temperature of Xiu Shiing is 50～60 ℃,
5. incubation time is 12～18 hours;
(2) modify in the rear pattern plate DNA purifying:
1. DEAE resin add-on is 0.5～1.5mg,
It is 2. centrifugal with washed with isopropyl alcohol and filtration back,
3. dry resin,
4. add being preheated in 55～75 ℃ of ultra-clean water of 50～60 μ l, and centrifugal,
5. the sodium hydroxide that adds 1mol/L makes its final concentration reach 0.2～0.4mmol/L, puts room temperature preservation,
6. add dehydrated alcohol and under-20 ℃, spend the night,
7. 0 ℃ centrifugal,
8. 70% washing with alcohol after drying,
9. after the ultra-clean water dissolution ,-20 ℃ of preservations;
(3) specific PCR is that the MSP reaction system is formulated as follows:
1. reaction volume 50 μ l:
PM PU
10×buffer 5μl 5μl
dNTP 5～8μl 5～8μl
MgCl
2 10～15μl 10～15μl
PM or PU 2～4 μ l
MoDNA 8～10μl 8～10μl
Taq enzyme 1～4u 1～4u
Add H
2O to 50ml adds the 50ml paraffin oil
2. reaction conditions:
Above-mentioned system is put into the PCR machine carries out following reaction:
At first 93～95 ℃ of sex change 5～10min do 24～34 circulations by the order of 93～95 ℃ of 30～45S → 55～65 ℃ 30～45S → 70～72 ℃ of 30～45S then, and 70～72 ℃ are extended 5～10min again, and product is preserved standby down for 4 ℃;
(4) yin and yang attribute contrast
Put Raji and HL in the MSP reaction
60Cell strain is done the positive and negative control respectively, establishes that not add template DNA be that MODNA makes blank;
Other application processes except that above-mentioned are routine techniques, and used medicine is analytical pure.
Specific PCR is that MSP reaction optimum condition is:
Do 25 circulations by 94 ℃ of 35S → 58 ℃ 35S → 71 ℃ of 35S.
The used centrifugal 9000～12000rpm that all selects in the application process.
The present invention has following outstanding advantage:
The CpG island methylation detection kit of the present invention's exploitation was mixed into 1: 10 with negative cells positive
4The time can measure the positive cell that methylates, highly sensitive, accurately, the production of this test kit and application can reach following application target:
(1) detects the clinical patients gene and whether methylate, the possibility of the existing canceration of this patient is described at CpG island gene methylation;
(2) thus the situation of measuring the CpG island gene methylation of tumour patient in therapeutic process can change treatment plan, with chemotherapy again behind the demethylation medicine demethylation, curative effect height;
(3) medicine of detection and screening demethylation;
(4) detect the result that tumour patient is used demethylation pharmacological agent.
Be widely used in the diagnosis of cancer and the screening of related drugs, will produce great economic benefit and social benefit.
Embodiment
Preparation CpG island methylation detection kit embodiment
Except the conventional reagent, the other drug division is as follows in the test kit:
Medicine in the present embodiment is 10 person-portions
(1) the different test kits that detect various disease of just forming of primer,
All kinds of primers are as follows: pancreas oncogene CPG primer
AGTGGAGGACAAGTCAGGGG
GGGCTTCGAGAGGACAGAG protein kinase related protein gene CPG primer
TCTATGCCACTGTTGGGGTTA
AGGGAGCTCCAAAATCTCCT mastocarcinoma gene 2CPG primer
TCCGTCAGATACTGACGGTTG
GCAGAGACAAAAGGGCAAGAAG acute leukemia genes involved primer
TCACMACACTTGCCCTCTCT
The AGGAAGACAGTGACGAAGACC generegulation factor 3 gene primers
CTCTGACCTCCACTCACTCAT
The AGCCTGTGCTCCTCCTGTGAG generegulation factor 27 gene primers
ATAGCCCTGGACATCACTGCC
GAGAGAGTGTGTTTCTCACTGGTP kinase-associated protein 27 gene primers
GTCTTCTTTGCAAGGATTTCTGC
ATACCTGGTACGCTGCTGATTGTP kinase-associated protein gene 27B primer
TTTGAAAGGGTCAGTCCTCCT
CATCCAAAGATACAGCATCTAAGTP kinase-associated protein gene 2L primer
AAAACAGCGTAGAGCCTGAGAAG
The AAAGATAAACATCCAAGCTCTTCCP16 gene primer
M1 GAGTACTTGGGGTGTGGCACT
M2 GATAACGATTCACAGACATTCP15 primer
M1 CGTTCGTATTTTGCGGTT
M2 GTACAATAACCGAACGACCGA
(2) extract the template DNA medicine
1. including concentration is the DNA extraction liquid 10ml of 200 μ g/ml or 300 μ g/ml or 400 μ g/ml Proteinase Ks,
2. be 24: 24: 1 with the saturated phenol/chloroform of the Tutofusin tris of 50mmol/L/primary isoamyl alcohol ratio, 10ml,
3. concentration range is 2.5～4.6ml/L, and the PH scope is 4.6～5.2 sodium-acetate, 10ml,
4. lymphocyte layering liquid 35ml;
(3) the used medicine of genomic modification
1. smart 12 μ g of the silicon of crossing with conventional DNA purification process purifying,
2. analytically pure Powdered quinhydrones 13mg,
3. analytically pure Powdered sodium bisulfite 3.5mg,
4. mineral oil 1.5ml;
(4) the DNA purifying medicine behind the genomic modification
1. the DNA purifying is with DEAE52 resin 1g,
2. analytically pure Virahol 20ml;
(5) specific PCR-MSP reaction system
1. the PCR damping fluid that methylates, 10 * buffer:
Sulfur acid ammonium 10mg, Tutofusin tris 10mg, PH8.8 beta-mercaptoethanol 10ml,
2. concentration is that the dNTP of 25mol/L is dTTP, dATP, each 10 μ l of four kinds of Nucleotide of dCTP, dGTP,
3. concentration is the MgCl of 2.5mmol/L
21.5ml;
(6) positive and negative control sample
Methylated positive sample DNA 15 μ g,
The non-negative specimen dna 15 μ g that methylate; With the said medicine general assembly in test kit.Application Example: Application Example 1
Immature B is that cell strain Raji is P
15Gene methylation positive cells strain (middle mountain is cured institute of tumour hospital and given); HL
60Be P
15The non-male myeloid cell strain that methylates of gene; K562 is P
15Red-the macronucleus of gene pure disappearance is that cell strain is provided by this chamber.In the present embodiment
1. cell cultures is got to go down to posterity and is used HL
60, K562, Raji cell strain change over to respectively in the RPMI1640100ml culturing bottle, RPMI1640 adds 5% deactivation calf serum, penicillin 100U/ml, 1% (v/v) glutamine.5%CO
2Incubator, was cultivated 72 hours by 37 ℃.
2. the collecting cell cell suspension changes the 10ml centrifuge tube over to, and the centrifugal 1800rpm of LXJ-II abandons supernatant, and 1 * PBS washes two times, and 1 * 10
7Cell changes the 2ml centrifuge tube over to.
3. digestion is containing 10
7The suspension of individual cell volume changes the centrifugation of 2ml tubule over to, removes clean supernatant.
4. extracting genome DNA adds the DNA extract that 1ml includes the Proteinase K of 200～400 μ g/ml, makes its final concentration reach 300 μ g/ml, fully stirs mixing, is thick, puts 37 ℃ of incubators and spends the night.Add 1ml phenol/chloroform/primary isoamyl alcohol mixed solution in the DNA extract, firmly shake vibration and put upside down mixing to oyster white was placed after 3 minutes, centrifugal 10000rpm under the room temperature, and in the TGL-16G whizzer centrifugal 20 minutes, draw supernatant, change new pipe repetition extracting 1 time over to; Get honest and upright and thrifty 0.6ml, add sodium-acetate 0.6ml, the dehydrated alcohol of 2 times of volume-20 ℃ precoolings is put upside down gently, visible white cotton-shaped DNA.The centrifugal 10000rpm of room temperature is 10 minutes then, abandons supernatant, and precipitation is washed secondary with 70% ethanol, centrifugally removes to go up to the greatest extent cleer and peaceful tube wall liquid, and drying at room temperature adds the about 500 μ l dissolving DNAs of ultra-clean water, and concentration and the quality of detection DNA.
5. dna solution 50 μ l, 10 times of thin ups are got in genomic dna quality inspection and concentration determination.Measure the value of OD260 with the 7521-ultraviolet spectrophotometer, and calculate the ratio of OD260/OD280, between 1.70-1.90, then sample is purer as if ratio, (＜1.7 pollutions have protein, need to repeat extractive process).Sample DNA content=OD260 * extension rate * 50 μ g/ml (1OD260 is equivalent to 50 μ g/ml double-stranded DNAs).
6. the bisulphite modified dna solution sample that contains 2 μ g of getting of genome adds 1mol/L sodium hydroxide, makes its final concentration reach 0.15mol/L, and DNA is sex change in high alkali liquid, and denaturation temperature is 37 ℃, 5 minutes sex change time.The purifying silicon essence that adds 0.5 μ g then adds freshly prepared 10mol/L analytical pure quinhydrones 10 μ l and 2mol/L sodium bisulfite 400 μ l again, fully behind the mixing, adds mineral oil and covers liquid level, puts into and transfers to 50 ℃ of incubators, hatches 12 hours.
7. modify the suction of rear pattern plate DNA purifying and abandon mineral oil, the about 0.5ml of substrate volume adds the 1.5mg/lDEAE52 resin, put upside down mixing for several times, pushing cylinder connects the filtration head, and resin compound is changed over to pushing cylinder, gently insert and cut somebody's hair, make mixture pass through filtering head, DNA is attracted on the resin, retention is in filtering head, with method washed with isopropyl alcohol filtering head, and filtering head received the 1.5ml whizzer mouth of pipe, centrifugal 10000rpm, room temperature 3 minutes, dry resin is received new centrifuge tube to filtering head then.Add 50 μ l and be preheated to 55 ℃ of ultrapure waters, placed 1 minute under the room temperature, centrifugal 10000rpm behind 30 seconds centrifugal eluted dnas, adds 1mol/L sodium hydroxide, makes its final concentration reach the 0.2mol/L room temperature and stops reduction reaction after following 5 minutes.Add 2 times of volumes-20 ℃ precooling dehydrated alcohol and under-20 ℃, spend the night, deposit D NA, 0 ℃ of following 12000rpm, centrifugal 13 minutes, abandon supernatant, 1ml 70% washing with alcohol desalts for 2 times, at every turn in 4 ℃ of 12000rpm, and centrifugal 5-10 minute, remove clean tube wall liquid, seasoning adds 20 μ l ultra-clean water dissolution ,-20 ℃ of preservations.
8.MSP the PCR reaction system of reaction system final volume 50 μ l contains 1 * MSPbuffer, four kinds of Nucleotide dTTP, dATP of 1.5mmol/L, dCTP, dGTP be totally 5 μ l, 7mmol/L MgCl
2, 300ng primer (single) modifies rear pattern plate DNA (MoDNA) 1 μ g, and Taq enzyme 2u specifically is formulated as follows:
P15M P15U
10 * buffer (PCR methylates), 5 μ l, 5 μ l
dNTP 5μl 5μl
MgCl
2 10μl 10μl
P
15M
1, P
15M
22 μ l (single)
P
15U
1, P
15U
22 μ l (single)
MoDNA 10μl 10μl
Taq enzyme 2u 2u
The MSP reaction conditions:
Add H
2O to 50 μ l, 30 μ l sterilization Valelinum Liquidum covers behind the mixing, slight centrifugal collection, and do three times by following condition:
For the first time: 93 ℃ of sex change 10min at first, do 30 circulations by 93 ℃ of 45S → 55 ℃ 45S → 70 ℃ of 45S again, 70 ℃ are extended 10min then,
For the second time: 94 ℃ of sex change 8min, do 28 circulations by 94 ℃ of 40S → 55 ℃ 40S → 71 ℃ of 40S again, 71 ℃ are extended 10min then,
For the third time: 95 ℃ of sex change 5min, do 25 circulations by 95 ℃ of 35S → 55 ℃ 35S → 72 ℃ of 35S again, 72 ℃ are extended 5min then, and product is preserved down for 4 ℃.
Put into Raji and HL in the MSP reaction
60Cell strain is done the positive and negative control respectively.Simultaneously, establish and do not add template MoDNA and make blank.
9.MSP specific degree and sensitivity determination
With wild-type DNA, two types of templates of MoDNA are measured Raji, HL
60, the P of K562
15M and P
15The U pcr amplification is understood its specificity.Raji and HL60 were pressed 1: 10 1: 10
2, 1: 10
3, 1: 10
4, 1: 10
5, 1: 10
6Carry out P after the mixing
15Methylated MSP measures its sensitivity.
10. detection sample results
A kind of in optional following two kinds of methods:
1. product adds 1.8% agarose and adds ethidium bromide, and electrophoresis is 45～60 minutes under 1.5～2.5v/cm, observations under Ultraviolet Detector, and take pictures; Analytical results in the gel electrophoresis analysis system,
2. product is used the fluorescent reagent mark, done the isoelectrofocusing quantitative PCR detection.
Application Example 2～10:
Immature B is that cell strain Raji is P
15The strain of gene methylation positive cells, in being institute of mountain doctor tumour hospital to give HL60 be P
15The non-male myeloid cell strain that methylates of gene; K562 is P
15Red-the macronucleus of gene pure disappearance is that cell strain is provided by this chamber.Divided by the lower section different outside, identical with Application Example 1.
(1) genome is bisulphite modified
Application Example sequence number 123456789 10
Hydro-oxidation sodium final concentration (mol/L) 0.15 0.15 0.2 0.2 0.3 0.3 0.4 0.4 0.25 0.25
37 ℃ of following sex change time (minute) 56789 10 58 10 15
The smart add-on μ of silicon g 0.51 0.6 07 0.8 0.9 1.0 1.2 1.4 1.6 2.0
Quinhydrones add-on μ l 10 12 15 20 25 30 35 20 25 30
Sodium bisulfite add-on μ l 400 420 440 460 490 520 550 580 500 480
Modify temperature ℃ 50 51 52 53 54 55 56 57 58 60
Incubation time hours 12 13 14 15 15 16 16 17 17 18
(2) modify rear pattern plate DNA purifying
DEAE52 resin (mg) 0.5 0.6 0.7 0.8 0.9 1.0 1.2 1.3 1.4 1.5
Add pure water temperature (℃) 55 58 62 65 68 70 72 75 60 65
Hydro-oxidation sodium final concentration mmol/L 0.2 0.2 0.25 0.25 0.3 0.30 0.35 035 0.4 0.4
(3) MSP reaction system
dNTP(μl) 5 5.5 5.75 6.0 6.25 6.5 6.75 7.0 7.5 8.0
MgCl(μl) 10 11 12 13 14 15 16 17 18 19
P
15U
1，P
15U
2(μl) 10 11 12 13 14 15 16 17 18 19
P
15M
1，P
15M
2(μl) 10 11 12 13 14 15 16 17 18 19
MoDNA(μl) 8 8 9 9 10 10 11 11 12 12
Taq enzyme (u) 1.0 1.5 2.0 2.0 2.5 2.5 3.0 3.0 3.5 4.0
(4) MSP reaction conditions:
Add H
2O to 50 μ l, mixing add 30 μ l Valelinum Liquidums, centrifugal collection, and do three times by following condition:
Application Example 2 and 7:
For the first time: 93 ℃ of sex change 10min at first, do 30 circulations by 93 ℃ of 45S → 58 ℃ 45S → 70 ℃ of 45S again, 70 ℃ are extended 10min then;
For the second time: 94 ℃ of sex change 8min, do 28 circulations by 94 ℃ of 40S → 58 ℃ 40S → 71 ℃ of 40S again, 71 ℃ are extended 8min then;
For the third time: 95 ℃ of sex change 5min, do 25 circulations by 95 ℃ of 35S → 58 ℃ 35S → 72 ℃ of 35S again, 72 ℃ are extended 5min then, and product is preserved down for 4 ℃.
Application Example 3 and 8:
For the first time: 93 ℃ of sex change 10min at first, do 30 circulations by 93 ℃ of 45S → 60 ℃ 45S → 70 ℃ of 45S again, 70 ℃ are extended 10min then;
For the second time: 94 ℃ of sex change 8min, do 28 circulations by 94 ℃ of 40S → 60 ℃ 40S → 71 ℃ of 40S again, 71 ℃ are extended 10min then;
For the third time: 95 ℃ of sex change 5min, do 25 circulations by 95 ℃ of 35S → 60 ℃ 35S → 72 ℃ of 35S again, 72 ℃ are extended 5min then, and product is preserved down for 4 ℃.
Application Example 4 and 9:
For the first time: 93 ℃ of sex change 10min at first, do 30 circulations by 93 ℃ of 45S → 62 ℃ 45S → 70 ℃ of 45S again, 70 ℃ are extended 10min then;
For the second time: 94 ℃ of sex change 8min, do 28 circulations by 94 ℃ of 40S → 62 ℃ 40S → 71 ℃ of 40S again, 71 ℃ are extended 10min then;
For the third time: 95 ℃ of sex change 5min, do 25 circulations by 95 ℃ of 35S → 60 ℃ 35S → 72 ℃ of 35S again, 72 ℃ are extended 5min then, and product is preserved down for 4 ℃.
Application Example 5 and 10:
For the first time: 93 ℃ of sex change 10min at first, do 30 circulations by 93 ℃ of 45S → 65 ℃ 45S → 70 ℃ of 45S again, 70 ℃ are extended 10min then;
For the second time: 94 ℃ of sex change 8min, do 30 circulations by 94 ℃ of 40S → 65 ℃ 40S → 71 ℃ of 40S again, 71 ℃ are extended 8min then;
For the third time: 95 ℃ of sex change 5min, do 30 circulations by 95 ℃ of 35S → 65 ℃ 35S → 72 ℃ of 35S again, 72 ℃ are extended 5min then, and product is preserved down for 4 ℃.
The MSP reaction conditions of embodiment 6 is with embodiment 1.
Claims (7)
1, CpG island methylation detection kit is characterized in that it includes following medicine:
(1) primer
Utilize the gene order of human genome, according to the base mispairing principle, it is P that primer is selected from last two genes of cell cycle
15 INK4B, P
16 INK4AGene, pancreas oncogene CPG, protein kinase related protein gene CPG, mastocarcinoma gene 2CPG, acute leukemia genes involved, the generegulation factor 3 genes, the generegulation factor 27 genes, GTP kinase-associated protein 27 genes, GTP kinase-associated protein gene 27B, any in the GTP kinase-associated protein gene 2L primer;
(2) medicine of extraction template DNA
1. include the DNA extraction liquid of the Proteinase K of 200～400 μ g/ml,
2. saturated phenol/chloroform/primary isoamyl alcohol system, their volume ratio are 20～25: 20～25: 1,
3. sodium-acetate,
4. lymphocyte layering liquid;
(3) genomic modification medicine:
1. silicon essence,
2. quinhydrones,
3. sodium bisulfite,
4. mineral oil;
(4) the DNA purifying medicine behind the genomic modification
1. DNA purifying DEAE resin,
2. Virahol;
(5) specificity MSP-PCR reaction system
1. the PCR damping fluid that methylates, 10 * buffer,
2. four kinds of Nucleotide are dNTP,
③MgCl
2，
4. high temperature resistant polysaccharase is the Taq enzyme;
(6) positive and negative control sample
1. the positive sample Raji cell that methylates,
2. the non-HL that methylates of negative sample
60Cell.
2, CpG according to claim 1 island methylation detection kit is characterized in that primer is a kind of in the following primer: pancreas oncogene CPG primer
AGTGGAGGACAAGTCAGGGG
GGGCTTCGAGAGGACAGAG protein kinase related protein gene CPG primer
TCTATGCCACTGTTGGGGTTA
AGGGAGCTCCAAAATCTCCT mastocarcinoma gene 2CPG primer
TCCGTCAGATACTGACGGTTG
GCAGAGACAAAAGGGCAAGAAG acute leukemia genes involved primer
TCACMACACTTGCCCTCTCT
The AGGAAGACAGTGACGAAGACC generegulation factor 3 gene primers
CTCTGACCTCCACTCACTCAT
The AGCCTGTGCTCCTCCTGTGAG generegulation factor 27 gene primers
ATAGCCCTGGACATCACTGCC
GAGAGAGTGTGTTTCTCACTGGTP kinase-associated protein 27 gene primers
GTCTTCTTTGCAAGGATTTCTGC
ATACCTGGTACGCTGCTGATTGTP kinase-associated protein gene 27B primer
TTTGAAAGGGTCAGTCCTCCT
CATCCAAAGATACAGCATCTAAGTP kinase-associated protein gene 2L primer
AAAACAGCGTAGAGCCTGAGAAG
The AAAGATAAACATCCAAGCTCTTCCP16 gene primer
M1 GAGTACTTGGGGTGTGGCACT
M2 GATAACGATTCACAGACATTCP15 primer
M1 CGTTCGTATTTTGCGGTT
M2 GTACAATAACCGAACGACCGA
3, CpG according to claim 1 island methylation detection kit is characterized in that extracting saturated phenol in the medicine of template DNA and is meant the saturated phenol of Tutofusin tris with 50mmol/L; Saturated phenol/chloroform/primary isoamyl alcohol volume ratio is 24: 24: 1.
4, CpG according to claim 1 island methylation detection kit is characterized in that genetic modification is meant the silicon essence of crossing with conventional DNA purification process purifying with silicon essence in the medicine, and quinhydrones and sodium bisulfite all adopt analytical pure dry powder.
5, the application of CpG island methylation detection kit comprises the collection of conventional sample; Extracting genome DNA, modification and purifying is characterized in that:
(1) in the genomic modification:
1. the smart DNA consumption of purifying silicon is 0.51～2 μ g/ part,
2. the fresh preparation of quinhydrones: with the quinhydrones constant volume of 10～13mg in 10ml ultra-clean water,
3. the fresh preparation of sodium bisulfite: with the sodium bisulfite constant volume of 2.9～3.2g in 10ml ultra-clean water,
4. the temperature of Xiu Shiing is 50～60 ℃,
5. incubation time is 12～18 hours;
(2) modify in the rear pattern plate DNA purifying:
1. DEAE resin add-on is 0.5～1.5mg,
It is 2. centrifugal with washed with isopropyl alcohol and filtration back,
3. dry resin,
4. add being preheated in 55～75 ℃ of ultra-clean water of 50～60 μ l, and centrifugal,
5. the sodium hydroxide that adds 1mol/L makes its final concentration reach 0.2～0.4mmol/L, puts room temperature preservation,
6. add dehydrated alcohol and under-20 ℃, spend the night,
7. 0 ℃ centrifugal,
8. 70% washing with alcohol after drying,
9. after the ultra-clean water dissolution ,-20 ℃ of preservations;
(3) specific PCR is that the MSP reaction system is formulated as follows:
1. reaction volume 50 μ l:
PM PU
10×buffer 5μl 5μl
DNTP 5～8μl 5～8μl
MgCl
2 10～15μl 10～15μl
PM or PU 2～4 μ l
MoDNA 8～10μl 8～10μl
Taq enzyme 1～4u 1～4u
Add H
2O to 50ml adds the 50ml paraffin oil
2. reaction conditions:
Above-mentioned system is put into the PCR machine carries out following reaction:
At first 93～95 ℃ of sex change 5～10min do 24～34 circulations by the order of 93～95 ℃ of 30～45S → 55～65 ℃ 30～45S → 70～72 ℃ of 30～45S then, and 70～72 ℃ are extended 5～10min, and product is preserved standby down for 4 ℃;
(4) yin and yang attribute contrast
Put Raji and HL in the MSP reaction
60Cell strain is done the positive and negative control respectively, establishes that not add template DNA be that MODNA makes blank;
Other application processes except that above-mentioned are routine techniques, and used medicine is analytical pure.
6, the application of CpG according to claim 5 island methylation detection kit is characterized in that specific PCR is that the MSP reaction conditions is:
Do 25 circulations by 94 ℃ of 35S → 58 ℃ 35S → 71 ℃ of 35S.
7, the application of CpG according to claim 6 island methylation detection kit is characterized in that the used centrifugal 9000～12000rpm that all selects in the application process.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011299673A CN1187456C (en) | 2001-11-27 | 2001-11-27 | CpG insular methylation test reagent kit and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011299673A CN1187456C (en) | 2001-11-27 | 2001-11-27 | CpG insular methylation test reagent kit and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1357636A true CN1357636A (en) | 2002-07-10 |
| CN1187456C CN1187456C (en) | 2005-02-02 |
Family
ID=4669602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011299673A Expired - Fee Related CN1187456C (en) | 2001-11-27 | 2001-11-27 | CpG insular methylation test reagent kit and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1187456C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050906A1 (en) * | 2002-11-29 | 2004-06-17 | Southeast University | Methylation dna detecting method |
| CN100516232C (en) * | 2006-07-19 | 2009-07-22 | 中国科学院遗传与发育生物学研究所 | Application of protein arginine methyl transferase 5 in cell detection and treatment of leukemia |
| CN101886130A (en) * | 2010-06-25 | 2010-11-17 | 中国环境科学研究院 | Method for quantitatively detecting deoxyribonucleic acid (DNA) demethylation capability of pollutant |
| CN102206708A (en) * | 2011-03-29 | 2011-10-05 | 北京大学 | Kit for detecting metastatic hepatoma cells in blood, marker and method thereof |
| CN102373286A (en) * | 2011-11-28 | 2012-03-14 | 中国科学院化学研究所 | Primer capable of detecting methylation of promoter of gene related to colonic adenocarcinoma |
| CN102424856A (en) * | 2011-09-09 | 2012-04-25 | 北京大学 | Kit for detecting phenylketonuria by use of DNA methylation method |
| CN103732759A (en) * | 2011-07-08 | 2014-04-16 | 表观基因组股份有限公司 | Methods and nucleic acids for determining the prognosis of a cancer subject |
| CN107245519A (en) * | 2017-06-06 | 2017-10-13 | 俞晓敏 | A kind of PWS and AS quick determination method |
| CN112375824A (en) * | 2020-11-13 | 2021-02-19 | 山东大学齐鲁医院 | Application of MSC as cervical cancer diagnosis, prognosis and/or treatment marker |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102719518B (en) * | 2011-03-29 | 2015-07-29 | 复旦大学 | A kind of method detecting DNA active demethylation |
-
2001
- 2001-11-27 CN CNB011299673A patent/CN1187456C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050906A1 (en) * | 2002-11-29 | 2004-06-17 | Southeast University | Methylation dna detecting method |
| CN100516232C (en) * | 2006-07-19 | 2009-07-22 | 中国科学院遗传与发育生物学研究所 | Application of protein arginine methyl transferase 5 in cell detection and treatment of leukemia |
| CN101886130A (en) * | 2010-06-25 | 2010-11-17 | 中国环境科学研究院 | Method for quantitatively detecting deoxyribonucleic acid (DNA) demethylation capability of pollutant |
| CN101886130B (en) * | 2010-06-25 | 2012-02-08 | 中国环境科学研究院 | Method for quantitatively detecting deoxyribonucleic acid (DNA) demethylation capability of pollutant |
| CN102206708A (en) * | 2011-03-29 | 2011-10-05 | 北京大学 | Kit for detecting metastatic hepatoma cells in blood, marker and method thereof |
| CN102206708B (en) * | 2011-03-29 | 2014-05-28 | 北京大学 | Kit for detecting metastatic hepatoma cells in blood, marker and method thereof |
| CN103732759A (en) * | 2011-07-08 | 2014-04-16 | 表观基因组股份有限公司 | Methods and nucleic acids for determining the prognosis of a cancer subject |
| CN102424856A (en) * | 2011-09-09 | 2012-04-25 | 北京大学 | Kit for detecting phenylketonuria by use of DNA methylation method |
| CN102424856B (en) * | 2011-09-09 | 2014-04-02 | 北京大学 | Kit for detecting phenylketonuria by use of DNA methylation method |
| CN102373286A (en) * | 2011-11-28 | 2012-03-14 | 中国科学院化学研究所 | Primer capable of detecting methylation of promoter of gene related to colonic adenocarcinoma |
| CN107245519A (en) * | 2017-06-06 | 2017-10-13 | 俞晓敏 | A kind of PWS and AS quick determination method |
| CN112375824A (en) * | 2020-11-13 | 2021-02-19 | 山东大学齐鲁医院 | Application of MSC as cervical cancer diagnosis, prognosis and/or treatment marker |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1187456C (en) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1286989C (en) | Biochip for detecting pathogenesis fungus | |
| CN1187456C (en) | CpG insular methylation test reagent kit and its application | |
| CN1710102A (en) | PCR detecting method of tumour associated gene mutation and reagent system | |
| CN1195070C (en) | Detection type gene chip for detecting various infectious desease and use thereof | |
| CN1406285A (en) | Method for detecting and quantifying adenovirus | |
| CN1824801A (en) | Real-time fluorescent PCR testing primer, probe and immobilized kit for citrus ulcer bacteria and testing process thereof | |
| CN101029336A (en) | Reagent kit for predicting serotonin re-uptake inhibitor medicine effect | |
| CN1772925A (en) | Detection kit for lung specificity X protein mRNA expression amount and its special primer and probe | |
| CN1891822A (en) | PH gene with specific mononucleotide pleimorphism, and its detecting method and use | |
| CN101065483A (en) | Method of identifying nucleotide polymorphisms | |
| CN1710097A (en) | Insitu method for rapid qualitative identification of red tide micro algae | |
| CN1311085C (en) | Preparation of mycobacterium molecular bacteria identification reagent box and use thereof | |
| CN1490050A (en) | Hepatitis A inactivated vaccine | |
| CN1814807A (en) | Norwalk virus expression detecting kit and its special primer and probe | |
| CN1772920A (en) | Fast and sensitive method of detecting virus infection titer of attenuated live hepatitis A vaccine | |
| CN1556216A (en) | Detecting method of blue tongue virus and reagent box | |
| CN1976942A (en) | Nucleic acid analysis method for identification of FC receptor polymorphisms | |
| CN1281752C (en) | Carcinoma of esophagus related gene-2 and use of coding protein thereof | |
| CN100342032C (en) | Detecting method of the schizophrenia susceptible gene and susceptible gene and use | |
| CN1193093C (en) | Primer for diagnosis of one or more kinds of cancer | |
| CN1154410A (en) | Method and kit for quantitation and detection of microorganisms | |
| CN1548552A (en) | Detection method and use of susceptible gene of schizophrenia | |
| CN1306574A (en) | Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same | |
| CN1786189A (en) | Detection method of hepatitis B virus genome drug resistance mutation | |
| CN101063166A (en) | Reagent case for predicting action effect of angiotensin conversion enzyme inhibitor medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: FAN HONGTAO GUO QIUYE Effective date: 20050805 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20050805 Address after: 510632 Guangdong city of Guangzhou province Tianhe District Shipai Co-patentee after: Fan Hongtao Patentee after: Jinan University Co-patentee after: Guo Qiuye Address before: 510632 Guangdong city of Guangzhou province Tianhe District Shipai Patentee before: Jinan University |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |